Fluctuating diversity in the HTLV-IIIB virus stock: Implications for neutralization and challenge experiments

AIDS Research and Human Retroviruses

Volumn 12, Issue 13, 1996, Pages 1297-1299

  Lockey, T D ^a   Slobod, K S ^a   Rencher, S D ^a   Srinivas, R V ^a   Hurwitz, J L ^a,b,c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c Department of Immunology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NOTE; PRIORITY JOURNAL; REPRODUCIBILITY; VIRUS ENVELOPE; VIRUS NEUTRALIZATION;

EID: 0029834002     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.1297     Document Type: Note

References (13)

1. Shaw GM, Hahn BH, Arya SK, Groopman JE, Gallo RC, and Wong-Staal F: Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science 1984;226:1165-1171.
2. Looney DJ, Fisher AG, Putney SD, Rusche JR, Redfield RR, Burke DS, Gallo RC, and Wong-Staal F: Type-restricted neutralization of molecular clones of human immunodeficiency virus. Science 1988;241:357-359.
3. Hahn BH, Shaw GM, Arya SK, Popovic M, Gallo RC, and Wong-Staal F: Molecular cloning and characterization of the HTLV-III virus associated with AIDS. Nature (London) 1984;312:166-169.
4. Moore JP, Yoshiyama H, Ho DD, Robinson JE, and Sodroski J: Antigenic variation in gp120s from molecular clones of HIV-1 LAI. AIDS Res Hum Retroviruses 1993;9:1185-1193.
5. Myers G, Korber B, Wain-Hobson S, Smith RF, and Pavlakis GN (eds.): Human Retroviruses and AIDS: A Compilation and analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos National Laboratory, Los Alamos, New Mexico, 1993.
6. Chakrabarti S, Brechling K, and Moss B: Vaccinia virus expression vector: Coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol Cell Biol 1985;5:3403-3409.
7. Ryan KW, Owens RJ, and Hurwitz JL: Preparation and use of vaccinia virus vectors for HIV protein expression and immunization. In: Immunology Methods Manual (Lefkovits I, ed.). Academic Press, London, 1996 (in press).
8. Hallenberger S, Tucker SP, Owens RJ, Bernstein HB, and Compans RW: Secretion of a truncated form of the human immunodeficiency virus type 1 envelope glycoprotein. Virology 1993;193:510-514.
9. Slobod KS, Rencher SD, Farmer A, Smith FS, and Hurwitz JL: HIV type 1 envelope sequence diversity in an inner city community. AIDS Res Hum Retroviruses 1994;10:873-875.
10. Ratner L, Haseltine W, Patarca R, Livak KJ, Starcich B, Josephs SF, Doran ER, Rafalski JA, Whitehorn EA, Baumeister K, Ivanoff L, Petteway SR Jr, Pearson ML, Lautenberger JA, Papas TS, Ghrayeb J, Chang NT, Gallo RC, and Wong-Staal F: Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature (London) 1985;313:277-284.
11. McKeating JA, Gow J, Goudsmit J, Pearl LH, Mulder C, and Weiss RA: Characterization of HIV-1 neutralization escape mutants. AIDS 1989;3:777-784.
12. Takahashi H, Merli S, Putney SD, Houghten R, Moss B, Germain RN, and Berzofsky JA: A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160. Science 1989;246: 118-121.
13. Hanson CV: Measuring vaccine-induced HIV neutralization: Report of a workshop. AIDS Res Hum Retroviruses 1994;10: 645-648.